Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.
The First Nasal Treatment for Anaphylaxis: FDA APPROVED!
Mohamad-Ali Salloum, PharmD • August 17, 2024
Share
Anaphylaxis is a severe, life-threatening allergic reaction that can occur rapidly, requiring immediate medical intervention. Traditionally, epinephrine autoinjectors have been the standard of care for such emergencies. However, the recent approval by the U.S. Food and Drug Administration (FDA) of a novel nasal spray, named neffy, marks a significant milestone in the management of anaphylactic reactions
What is Neffy?
Neffy (epinephrine nasal spray) is the first of its kind for the emergency treatment of allergic reactions (Type I), including anaphylaxis, in adult and pediatric patients who weigh at least 30 kilograms (approximately 66 pounds). This approval is particularly noteworthy as it introduces the first non-injectable form of epinephrine, potentially reducing barriers to rapid treatment due to needle phobia
Why Neffy was approved?
The approval of Neffy was based on four studies involving 175 healthy adults, which demonstrated that the epinephrine concentrations in the blood following administration of Neffy were comparable to those achieved with approved epinephrine injection products. Additionally, Neffy showed similar increases in blood pressure and heart rate, which are critical effects of epinephrine in treating anaphylaxis.
How is it Administered?
Neffy is administered as a single dose nasal spray into one nostril and may be given a second dose if symptoms do not improve or worsen. It is important to note that certain nasal conditions, such as nasal polyps or a history of nasal surgery, may affect the absorption of Neffy. In such cases, patients are advised to consult with healthcare professionals regarding the use of injectable epinephrine products
Conclusion:
The introduction of neffy is a welcome addition to the arsenal of anaphylaxis treatments, offering a needle-free alternative that may encourage more timely administration of life-saving epinephrine. As with any new medical product, ongoing monitoring and real-world data will be essential to assess the long-term efficacy and safety of this innovative treatment option.
References :
-FDA Approves First Nasal Spray for Treatment of Anaphylaxis.
List of Services
ABOUT THE AUTHOR
Mohamad-Ali Salloum, PharmD
Share
Recent articles:
Explore evidence-based insights into ACE inhibitors, calcium channel blockers, and ARBs for hypertension management.
Discover the latest scientific evidence (2022–2025) on Branched-Chain Amino Acids (BCAAs)—their role in muscle recovery, performance enhancement, and safety.
Explore the benefits of Combination therapy for patients with Hypertension.
Explore the evolution of hypertension treatment guidelines from JNC to ACC/AHA, ESC/ESH, and WHO in an interactive timeline with thresholds, goals, and practical insights.
Discover why hypertension is called the silent killer, its global impact, hidden dangers, and practical steps for prevention and management. Learn how to protect your heart, brain, and kidneys today.
Discover the science-backed benefits of creatine supplementation for strength, power, and cognitive performance. Learn how it works, safe dosing strategies, and practical tips for athletes and everyday fitness enthusiasts.
Discover how confirmation bias shapes our thinking, decision-making, and perception—and learn strategies to overcome it for clearer, objective insights.
Discover how scientists uncovered a hidden “pain switch” in the brain that can silence chronic pain during survival states. Learn how Y1 receptor neurons and neuropeptide Y could revolutionize pain treatment and explore natural ways to activate this mechanism.
Discover why social media is so addictive, its impact on mental health, productivity, and relationships, and practical tips to regain control and break free from the endless scroll.
Discover how a nanoparticle-based “super vaccine” prevented melanoma, pancreatic, and breast cancers in mice. Learn the science, real-world implications, and what’s next for cancer prevention.